FORA Capital, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1742435 MIAMI, FL

Position in ALNY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,479,319

+$101,065 QoQ

Shares Held

4,471

+29.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FORA Capital, LLC holds $20,857,761 across 23 Biotechnology names. ALNY ranks #5 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	23,625	$1,481,287
2	KRYS	Krystal Biotech, Inc.	5,732	$1,480,690
3	RVMD	Revolution Medicines, Inc.	15,218	$1,479,950
4	ROIV	Roivant Sciences Ltd.	53,409	$1,479,429
5	ALNY	Alnylam Pharmaceuticals, Inc. This page	4,471	$1,479,319
6	IONS	Ionis Pharmaceuticals Inc	19,693	$1,478,747
7	ABVX	Abivax S.A.	13,186	$1,468,261
8	TERN	Terns Pharmaceuticals, Inc.	27,120	$1,429,766

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,479,319	4,471	+29.0%	Shares	Sole	2026-05-15
2025-12-31	$1,378,254	3,466	+27.5%	Shares	Sole	2026-02-13
2025-09-30	$1,239,864	2,719	-68.5%	Shares	Sole	2025-11-13
2025-03-31	$2,328,652	8,624	-32.1%	Shares	Sole	2025-05-14
2024-12-31	$2,987,966	12,698	+77.0%	Shares	Sole	2025-02-14
2024-06-30	$1,743,039	7,173	+320.7%	Shares	Sole	2024-08-13
2023-12-31	$326,354	1,705	-80.6%	Shares	Sole	2024-02-14
2022-09-30	$1,756,203	8,774	+293.6%	Shares	Sole	2022-11-14
2021-09-30	$420,857	2,229	-16.3%	Shares	Sole	2021-11-15
2021-06-30	$451,601	2,664	-62.1%	Shares	Sole	2021-08-16
2020-06-30	$1,040,620	7,026	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.